Drug delivery improvements aid in regulating medicine dosages while giving local anesthetics to relieve pain and burns, among other applications.
FREMONT, CA: The medication delivery area has experienced a great deal of innovation over the years, and there are no indicators that this trend will slow down anytime soon.
Some have proposed enhancements to conventional techniques such as insulin delivery devices and inhalers, while others have opened new medication delivery methods via several approaches.
Among the most innovative businesses in the field are Medtronic and Tandem Diabetes Care. Some up-and-comers are also beginning to make waves as research continues to unearth novel therapeutic delivery methods.
Below are some types of drug delivery innovations:
Closed-loop insulin delivery
Although closed-loop insulin delivery is not a novel concept, it continues to gain traction in the diabetes care market.
Tandem Diabetes Care is a market leader in this field with its t:slim X2 insulin pump and Control-IQ superior hybrid closed-loop technology for Type 1 diabetes management. The FDA authorized the system in December 2019 for use with Dexcom's G6 continuous glucose monitor (CGM) and Abbott's FreeStyle Libre CGM.
For instance, Medtronic also manufactures a closed-loop insulin administration system called the MiniMed, the first of its kind to receive global clearance in 2016. Medtronic and Tandem signed a non-exclusive patent cross-license arrangement to develop rival diabetic treatment technologies.
Closed-loop automated insulin delivery systems can monitor glucose levels or, in the case of Tandem, pair with continuous glucose monitors (CGMs) to automatically inject or withhold insulin based on the results. Additionally, they have been referred to an as artificial pancreas.
While the technology has been available for a few years, there is still the possibility for growth in the closed-loop insulin delivery field.
The drug delivery patch developed by Enable Injections
With the enFuse, Enable Injections is developing a subcutaneous drug delivery platform that acts as an on-body patch.
Outside of the hospital, enFuse offers patient-administered subcutaneous delivery of high-volume medicines. The self-contained medication delivery system on the on-body drug delivery platform is compatible with ordinary syringes and vial container forms.
The platform is intended for subcutaneous injection of massive amounts ranging from 5ml to 50ml in a regulated manner. According to the business, the device can provide patients and caregivers with an alternative approach to administering parenteral treatments subcutaneously outside the doctor's office.